Health Canada
- Status: approved
🇨🇦 Infliximab CT-P13 in Canada
Infliximab CT-P13 (Infliximab CT-P13) regulatory status in Canada.
Marketing authorisation
Infliximab CT-P13 in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Frequently asked questions
Is Infliximab CT-P13 approved in Canada?
Yes. Health Canada has authorised it.
Who is the marketing authorisation holder for Infliximab CT-P13 in Canada?
Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives is the originator. The local marketing authorisation holder may differ — check the official source linked above.